Engaged Capital
13F Holdings and Portfolio Analysis
Glenn W. Welling 2019 Q2 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Engaged Capital Overview
Engaged Capital held 9 stocks in 2019 Q2, with total market value around $0.82B.
Engaged Capital's top five holdings in 2019 Q2: HAIN CELESTIAL GROUP INC(HAIN) 56.12%, UPBOUND GROUP INC(UPBD) 17.28%, APOGEE ENTERPRISES INC(APOG) 8.93%, NCR VOYIX CORP(VYX) 4.07%, SUNOPTA INC COMMON STOCK(STKL) 3.49%.
- Portfolio Value
- $0.82B
- Current Holdings
- 9 stocks
- New / Increased
- 0 / 2
- Reduced / Exited
- 0 / 3
Current Holdings
| 1 | HAIN CELESTIAL GROUP INCHAIN | 0.46 | 56.12% | 21.07 +24.95% | $21.90 | - | $31.30 | +4.21 | 2.50 | -$0.20B-30.03% | Increased |
| 2 | UPBOUND GROUP INCUPBD | 0.14 | 17.28% | 5.33 - | $26.63 | - | $4.82 | 0.00 | 2.75 | +$0.12B+452.60% | Held |
| 3 | APOGEE ENTERPRISES INCAPOG | 0.07 | 8.93% | 1.69 - | $43.44 | - | $43.70 | 0.00 | 1.75 | -$0.00B-0.60% | Held |
| 4 | NCR VOYIX CORPVYX | 0.03 | 4.07% | 1.08 - | $31.10 | - | $30.06 | 0.00 | 2.00 | +$0.00B+3.46% | Held |
| 5 | SUNOPTA INC COMMON STOCKSTKL | 0.03 | 3.49% | 8.73 - | $3.29 | - | $6.28 | 0.00 | 3.25 | -$0.03B-47.63% | Held |
| 6 | MAGELLAN HEALTH INCCUSIP 559079207 | 0.03 | 3.43% | 0.38 +66.73% | $74.23 | - | $63.83 | +0.15 | 0.75 | +$0.00B+16.30% | Increased |
| 7 | DEL FRISCOS RESTAURANT GROUPCUSIP 245077102 | 0.03 | 3.22% | 3.33 - | $7.96 | - | $7.15 | 0.00 | 0.75 | +$0.00B+11.33% | Held |
| 8 | TIVO CORP COMCUSIP 88870P106 | 0.02 | 2.26% | 2.52 - | $7.37 | - | $19.52 | 0.00 | 3.00 | -$0.03B-62.25% | Held |
| 9 | INNERWORKINGS INC COMCUSIP 45773Y105 | 0.01 | 1.20% | 2.58 - | $3.82 | - | $5.26 | 0.00 | 1.00 | -$0.00B-27.44% | Held |
Showing 1-9 of 9
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2019 Q2.
| 1 | BENCHMARK ELECTRONICS INCBHE | 0.34 | 4.25 | $24.86 | $26.25 | +$0.00B+5.62% |
| 2 | ARATANA THERAPEUTICS INC COMCUSIP 03874P101 | 2.42 | 1.25 | $4.98 | $3.60 | -$0.00B-27.71% |
| 3 | MEDIFAST INCMED | 0.01 | 0.25 | $127.56 | $127.56 | $0.00B0.00% |
Showing 1-3 of 3
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.